Opexa Therapeutics Inc (NASDAQ: OPXA) is having a relatively strong day in the market today; at least, it has been in the green all morning. The reason is relatively simple. Today is the day that investors will vote with regard to a proposed merger. At the moment (10:36), OPXA is trading at $1.10 per share … Read more
Opexa Therapeutics Inc (NASDAQ: OPXA) is having an overwhelmingly strong morning so far today, and for good reason. The company announced that it has entered into an agreement to merge with Acer Therapeutics. This is leading to excitement among investors who are sending the stock upward. As is usually the case, our partners at Trade … Read more
[adrotate group=”5″] Opexa Therapeutics Inc (NASDAQ: OPXA) Investors in Opexa Therapeutics were crushed on Friday, with the stock tumbling more than 69% on enormous volume, settling at $1.05 a share, a level not seen since the company implemented a 1:8 reverse stock split in 2015. Incidentally, the volume traded on Friday is roughly equal to … Read more
The US stock market has taken a beating recently, with biotechs taking the brunt of the punishment after comments made by Hillary Clinton. However, today is a relatively green day across the board, and there are several biotech stocks that are making a comeback. Here are 5 biotechs that are making a comeback that’s well … Read more
While this morning was a bit of a rough start for biotech stocks, it seems as though things are changing rather quickly from red to green. In the space, there are several stocks gaining, but I’ve dug out what are some of the biggest gainers so far today. Here’s the scoop… CIGNA Corporation Climbs On … Read more
Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I … Read more
If you looked at the biotech space yesterday, you were looking at a sea of red. However, today, things are working out to be much different. There are several biotech stocks out there that are doing very well. With that said, here is a list of my top 5 biotech picks for the day. Watch … Read more
THE WOODLANDS, Texas–(BUSINESS WIRE)– Opexa Therapeutics, Inc.(NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO), is pleased to announce that Dr. Jason Kralic has joined the company in the new role of Vice President of Business Development. Dr. Kralic will be responsible for business development activities, … Read more
Opexa Therapeutics Inc (NASDAQ: OPXA) This article was originally published at Warrior Trading News! Opexa Therapeutics is a clinical stage biopharma company that proved today that it’s getting closer and closer to a product launch. At the 2015 Microcap Conference, President and CEO of OPXA, Neil K. Warma gave a presentation that clearly excited investors. … Read more
Opexa Therapeutics Inc (NASDAQ: OPXA) Opexa Therapeutics stock is climbing today as a result of a presentation at the 2015 Marcum Microcap Conference that just wrapped up recently. In the presentation, OPXA CEO, Neil K. Warma announced financial information as well as information on the company’s pipeline and goals moving forward; and I have to … Read more